JOHN DEBUS: Open Payments
NPI 1457354094 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 39 payments from 11 companies in 2025. Trend: 2023 $15,644 · 2024 $1,336 · 2025 $1,327
Food & beverage: $1,177Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $432 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $196 |
| Bausch Health US, LLC | 10 | $195 |
| Axsome Therapeutics, Inc. | 3 | $173 |
| Amgen Inc. | 6 | $126 |
| MILLICENT US INC | 3 | $63 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| HARMONY BIOSCIENCES LLC | 1 | $30 |
| Exact Sciences Corporation | 1 | $27 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
Products named: XYWAV, LUMRYZ, Auvelity, WELLBUTRIN, OTEZLA, APLENZIN, INTRAROSA, Sunosi.
Industry payments across TX — which companies pay providers there.
